Pen Needles Market is Growing in Huge Demand from 2020 to 2026 | Becton, Dickinson and Company, Novo Nordisk A/S and more

The global pen needles market is forecast to reach USD 2.48 Billion by 2026, according to a new report by Reports and Data. Pen needles are used for the drug administration for many diseases and are used by both healthcare professionals and patients themselves. They have become popularly accepted with the advancements in therapy and a supportive reimbursement structure in many nations.

Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/2124

According to the World Health Organization (WHO), from 2015 to 2050, the aged population across the globe will be rise from 12% to 22% of the total global population. Owing to this, the incidence of target diseases such as chronic diseases and cancer is expected to grow and, in return, will boost the demand. An increase in healthcare expenditure across the globe also supports the adoption of user-friendly technologies. According to the American Diabetes Association, the annual healthcare cost in the U.S. increased by 26% during the last five years due to increased diabetes incidences.

Companies considered and profiled in this market study
Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, B. Braun Melsungen AG, HTL-Strefa S.A., Terumo Corporation, Owen Mumford Ltd., Allison Medical Inc., Ultimed, Inc., and Arkray, Inc., among others.

For the purpose of this report, Reports and Data have segmented into the global Pen Needles market on the basis of type, length, therapy, usability, distribution channel, end-uses, and region:

Type Outlook (Revenue, USD Billion; 2016-2026)
Standard pens
Safety pen needles

Length Outlook (Revenue, USD Billion; 2016-2026)
4 mm pens
5 mm pens
6 mm pens
8 mm pens
10 mm pens
12 mm pens

This report comes with amazing customization options, to buy now contact us here: https://www.reportsanddata.com/checkout-form/2124

Therapy Outlook (Revenue, USD Billion; 2016-2026)
Insulin therapy
Glucagon-like peptide-1 (glp-1) therapy
Growth hormone therapy
Others

Usability Outlook (Revenue, USD Billion; 2016-2026)
Reusable pens
Disposable pens

Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)
Retail
Non-retail

End-Use Outlook (Revenue, USD Billion; 2016-2026)
Home healthcare
Hospitals
Over the counter (OTC)
Clinics
Others

Regional Outlook (Revenue, USD Billion; 2016-2026)
North America
Europe
Asia Pacific
MEA
Latin America

Further key findings from the report suggest
1. The standard pen needles are used by the healthcare professionals as well as individual patients for injecting a variety of medications into the body. These pens are most commonly used by people with diabetes who often require multiple dosage of insulin injections daily.

2. 4mm pen needles provide equal glycaemic control when compared to longer needles. 4mm pen needles have been shown to cause less pain as compared to longer needles, reduce any anxiety associated with injection, and provide an overall improved experience, which helps people with diabetes adhere more to an insulin injectable therapy program and also improves outcomes.

3. The fact insulin cannot be consumed orally makes insulin pen an integral part of insulin therapy. The underlying reason for the increasing popularity of insulin pens is that it is accurate, simple, and convenient in terms of usage as compared to syringe and vial.

4. Retailer segment is primarily driven by consumers falling under the developing regions cohort. The rising cases of diabetes is a major driving factor for the manufacturers. Companies can tap into these unique market characteristics by building a robust distribution system based on retail sales.

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies @ https://www.reportsanddata.com/report-detail/pen-needles-market

Aims of the study
1. To curate a concise report of the market, highlighting the key vendors and significant changes observed in the market
2. Examine the existing and emergent trends and promising technological innovations in the market
3. Assessment of market values, modeled values, and international trade values, to deduce the market volume
4. Offered research-backed insights for the parent market, cost analysis, and prevailing industry trends
5. Calculate capacity utilization rate

Contact Us

John Watson
Head of Business Development
Address- 40 Wall St. 28th floor New York City, USA
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About us

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client?EUR(TM)s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.